NeuroBo Pharmaceuticals (NRBO)
(Delayed Data from NSDQ)
$3.19 USD
-0.07 (-2.15%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.38 +0.19 (5.96%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.82 | 0.00% |
Earnings Summary
For their last quarter, NeuroBo Pharmaceuticals (NRBO) reported earnings of -$1.85 per share, missing the Zacks Consensus Estimate of -$1.38 per share. This reflects a negative earnings surprise of 34.06%. Look out for NRBO's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.82 per share, reflecting a year-over-year decrease of 13.89%.
Earnings History
Price & Consensus
Zacks News for NRBO
4 Undervalued Medical Stocks to Buy Amid High Market Volatility
NRBO: What are Zacks experts saying now?
Zacks Private Portfolio Services